Cargando…
Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses
BACKGROUND: Pulmonary Hypertension is a severe and incurable disease with poor prognosis. A suite of new disease-specific measures – the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) – was recently developed for use in this condition. The purpose of this study was to develop and validate...
Autores principales: | McKenna, Stephen P, Ratcliffe, Julie, Meads, David M, Brazier, John E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546377/ https://www.ncbi.nlm.nih.gov/pubmed/18718016 http://dx.doi.org/10.1186/1477-7525-6-65 |
Ejemplares similares
-
Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire
por: Reis, Abílio, et al.
Publicado: (2016) -
ADAPTATION AND VALIDATION OF THE CAMBRIDGE PULMONARY HYPERTENSION OUTCOME REVIEW (CAMPHOR) FOR CROATIA
por: Hećimović, Ana, et al.
Publicado: (2019) -
The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR)
por: Cima, Katharina, et al.
Publicado: (2012) -
Adaptation and validation of the quality of life assessment of the Cambridge pulmonary hypertension outcome review (CAMPHOR) for Brazil
por: Corrêa, Ricardo Amorim, et al.
Publicado: (2020) -
Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands
por: Wapenaar, M., et al.
Publicado: (2016)